Lv1
30 积分 2025-09-17 加入
Oncolytic adenovirus in combination with PD-L1-targeted radioimmunotherapy exerts synergistic antitumor effect against pancreatic cancer
2天前
待确认
An oncolytic virus–T cell chimera for cancer immunotherapy
4天前
已完结
In vivo dendritic cell reprogramming for cancer immunotherapy
4天前
已完结
Enhancing Oncolytic Adenovirus Replication by Early Region 1A Protein‐Mediated Degradation of E1A Binding Protein p300
4天前
已完结
Coxsackievirus and adenovirus receptor expression facilitates enteroviral infections to drive the development of pancreatic cancer
8天前
已完结
Synthetic super-enhancers enable precision viral immunotherapy
8天前
已完结
Hepatic TM6SF2 activates antitumour immunity to suppress metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma and boosts immunotherapy
10天前
已完结
MicroRNA-223 attenuates hepatocarcinogenesis by blocking hypoxia-driven angiogenesis and immunosuppression
10天前
已完结
Targeting the ALK–CDK9-Tyr19 kinase cascade sensitizes ovarian and breast tumors to PARP inhibition via destabilization of the P-TEFb complex
11天前
已完结
Safety and dose-escalation study of a targeted oncolytic adenovirus, suratadenoturev (OBP-301), in patients with refractory advanced liver cancer: Phase I clinical trial
11天前
已关闭
皖公网安备34019202002308
